Filing Details
- Accession Number:
- 0001209191-15-075198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-13 13:29:21
- Reporting Period:
- 2015-10-13
- Filing Date:
- 2015-10-13
- Accepted Time:
- 2015-10-13 13:29:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1557746 | Aclaris Therapeutics Inc. | ACRS | Pharmaceutical Preparations (2834) | 460571712 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509160 | Vivo Ventures Fund Vii, L.p. | C/O Vivo Capital 575 High Street, Suite 201 Palo Alto CA 94301 | No | No | Yes | No | |
1538309 | Vivo Ventures Vii Affiliates Fund, L.p. | C/O Vivo Capital 575 High Street, Suite 201 Palo Alto CA 94301 | No | No | Yes | No | |
1565020 | Vivo Ventures Vii, Llc | C/O Vivo Capital 575 High Street, Suite 201 Palo Alto CA 94301 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-10-13 | 3,360,408 | $0.00 | 3,657,147 | No | 4 | C | Indirect | By Vivo Ventures Fund VII, L.P. |
Common Stock | Acquisiton | 2015-10-13 | 444,850 | $11.00 | 4,101,997 | No | 4 | P | Indirect | By Vivo Ventures Fund VII, L.P. |
Common Stock | Acquisiton | 2015-10-13 | 73,238 | $0.00 | 79,705 | No | 4 | C | Indirect | By Vivo Ventures VII Affiliates Fund, L.P. |
Common Stock | Acquisiton | 2015-10-13 | 9,695 | $11.00 | 89,400 | No | 4 | P | Indirect | By Vivo Ventures VII Affiliates Fund, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Vivo Ventures Fund VII, L.P. |
No | 4 | P | Indirect | By Vivo Ventures Fund VII, L.P. |
No | 4 | C | Indirect | By Vivo Ventures VII Affiliates Fund, L.P. |
No | 4 | P | Indirect | By Vivo Ventures VII Affiliates Fund, L.P. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2015-10-13 | 8,467,943 | $0.00 | 2,454,476 | $0.00 |
Common Stock | Series A Preferred Stock | Disposition | 2015-10-13 | 184,557 | $0.00 | 53,494 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2015-10-13 | 1,779,400 | $0.00 | 515,768 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2015-10-13 | 38,782 | $0.00 | 11,241 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2015-10-13 | 1,346,068 | $0.00 | 390,164 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2015-10-13 | 29,337 | $0.00 | 8,503 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The total represents shares received upon conversion of shares of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock.
- Effective upon the closing of the issuer's initial public offering of its common stock, each share of preferred stock automatically converted into 0.289855 shares of common stock. The preferred stock had no expiration date.
- Vivo Ventures VII, LLC ("VV LLC") is the general partner of Vivo Ventures Fund VII, L.P. ("VVF"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. In addition, each of Albert Cha, a director of the issuer, Frank Kung and Edgar Engleman is a managing member of VV LLC and may be deemed to share voting and dispositive power over the securities held by VVF. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
- VV LLC is the general partner of Vivo Ventures VII Affiliates Fund, L.P. ("VVAF"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. In addition, each of Albert Cha, a director of the issuer, Frank Kung and Edgar Engleman is a managing member of VV LLC and may be deemed to share voting and dispositive power over the securities held by VVAF. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.